Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01527292 · ClinicalTrials.gov registry record · NA
Phase II Trial of Stereotactic Radiation Therapy (SRT) Versus SRT Plus Vertebral Augmentation Procedure (VAP) for Vertebral Metastasis
A NA study, sponsored by University of Louisville.
- Terminated
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT01527292 is a NA study that was terminated before completion, run by University of Louisville. The registered enrollment target is 3 participants.
The verdict
NCT01527292, a NA study, was terminated before completion, sponsored by University of Louisville.
- TERMINATED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
The purpose of this study is to determine pain control rate (Percentage of patients in each arm that achieve pain control) at the treated site(s) at 1 month, 2-4 months and 5-6 months post-treatment.
Interventions
- RADIATION Stereotactic Radiation Therapy
- RADIATION SRT with Vertebral Augmentation Procedure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2012-02 |
| Est. Completion | 2015-09-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01527292
The ClinicalTrials.gov registry entry for NCT01527292 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Louisville, which has 217 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Stereotactic Radiation Therapy is the first listed.
NCT01527292 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01527292 about?
NCT01527292 is a clinical study titled "Phase II Trial of Stereotactic Radiation Therapy (SRT) Versus SRT Plus Vertebral Augmentation Procedure (VAP) for Vertebral Metastasis". The purpose of this study is to determine pain control rate (Percentage of patients in each arm that achieve pain control) at the treated site(s) at 1 month, 2-4 months and 5-6 months post-treatment.
What is the current status of trial NCT01527292?
This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2012-02. Estimated completion is 2015-09-02.
What interventions are being tested in trial NCT01527292?
The interventions under investigation include: Stereotactic Radiation Therapy (RADIATION), SRT with Vertebral Augmentation Procedure (RADIATION).
Who is sponsoring clinical trial NCT01527292?
This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.